Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers Please visit their website for more information.
*Proprietary Buy Sell Volume Indicator
| Revenue: $5.80B |
| Revenue Growth (YOY): -15.64% |
| Profit (% of Rev): 58.66% |
| Income (% of Rev): 14.11% |
| Income Growth (YOY): -27.55% |
| Operating Income: $958M |
| Operating Cash Flow: $1.51B |
| Operating Cash Flow Growth (YoY): -9.51% |
| Annual Dividend Yield: 0.10% |
| Total Assets: $80.61B |
| Total Liabilities: $29.31B |
| Cash & Equivalent: $2.63B |
| Total Debt: $17.52B |
| Debt/Equity: 0.34 |
| Quick Ratio: 1.01 |
| Current Ratio: 1.37 |
| Price/Book: 3.88 |
| Price/Earnings: 60.86 |
| EBITDA: $1.66B |
| EPS: 1.13 |
Our proprietary analysis employs a weighted average approach integrating both functional and technical parameters, tailored to the sector, industry, and microeconomic factors. This methodology assigns dynamic weights to the parameters, with a focus on recent trends, ensuring a nuanced evaluation for informed investment decisions. Considering all the above parameters, in addition to some of the derived parameters of the stock in conjunction with its sector and macroeconomic conditions, our proprietary Weighted Average AI model gives a rank of Sell.
TheoryofStocks is not registered as an investment advisor with any regulatory authority. The information provided on this Website is for educational purposes only and should not be construed as financial or investment advice. By continuing to use this site, you are agreeing to the Terms of Use and Privacy Policy. Please read our Disclaimer.
Contact @ support@theoryofstocks.com
© 2024 Stock Articles. All rights reserved.